Neil Almstead's most recent trade in PTC Therapeutics Inc was a trade of 3,056 Common Stock done at an average price of $69.4 . Disclosure was reported to the exchange on Feb. 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 69.36 per share. | 18 Feb 2026 | 3,056 | 112,140 (0%) | 0% | 69.4 | 211,964 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 69.35 per share. | 18 Feb 2026 | 65 | 6,726 (0%) | 0% | 69.4 | 4,508 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 76.45 per share. | 08 Jan 2026 | 881 | 115,196 (0%) | 0% | 76.4 | 67,352 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 76.46 per share. | 08 Jan 2026 | 59 | 6,791 (0%) | 0% | 76.5 | 4,511 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 76.95 per share. | 06 Jan 2026 | 1,279 | 117,103 (0%) | 0% | 76.9 | 98,419 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 77.48 per share. | 06 Jan 2026 | 1,026 | 116,077 (0%) | 0% | 77.5 | 79,494 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 76.94 per share. | 06 Jan 2026 | 54 | 6,902 (0%) | 0% | 76.9 | 4,155 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 77.48 per share. | 06 Jan 2026 | 52 | 6,850 (0%) | 0% | 77.5 | 4,029 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 43,750 | 43,750 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 17,500 | 118,382 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 520 | 6,956 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 25 Nov 2025 | 47,624 | 148,249 (0%) | 0% | 33.0 | 1,572,544 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 47,624 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 83.33 per share. | 25 Nov 2025 | 21,844 | 112,891 (0%) | 0% | 83.3 | 1,820,261 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 82.55 per share. | 25 Nov 2025 | 13,514 | 134,735 (0%) | 0% | 82.6 | 1,115,581 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 11,399 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 25 Nov 2025 | 11,399 | 112,024 (0%) | 0% | 33.0 | 376,395 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 84.42 per share. | 25 Nov 2025 | 9,171 | 103,720 (0%) | 0% | 84.4 | 774,216 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 8,410 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 25 Nov 2025 | 8,410 | 109,035 (0%) | 0% | 18.0 | 151,464 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 83.39 per share. | 25 Nov 2025 | 4,834 | 103,446 (0%) | 0% | 83.4 | 403,107 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 82.61 per share. | 25 Nov 2025 | 3,744 | 108,280 (0%) | 0% | 82.6 | 309,292 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 83.41 per share. | 25 Nov 2025 | 3,663 | 102,582 (0%) | 0% | 83.4 | 305,531 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.15 per share. | 25 Nov 2025 | 3,095 | 100,625 (0%) | 0% | 85.1 | 263,539 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 82.82 per share. | 25 Nov 2025 | 2,790 | 106,245 (0%) | 0% | 82.8 | 231,068 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 84.54 per share. | 25 Nov 2025 | 2,621 | 100,825 (0%) | 0% | 84.5 | 221,579 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 2,475 | 8,410 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 25 Nov 2025 | 2,475 | 103,100 (0%) | 0% | 18.0 | 44,575 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 2,020 | 47,624 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 25 Nov 2025 | 2,020 | 102,645 (0%) | 0% | 33.0 | 66,700 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 84.56 per share. | 25 Nov 2025 | 1,757 | 100,825 (0%) | 0% | 84.6 | 148,572 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 83.44 per share. | 25 Nov 2025 | 990 | 101,199 (0%) | 0% | 83.4 | 82,606 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 82.63 per share. | 25 Nov 2025 | 911 | 102,189 (0%) | 0% | 82.6 | 75,276 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 83.35 per share. | 25 Nov 2025 | 862 | 101,094 (0%) | 0% | 83.4 | 71,848 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 82.63 per share. | 25 Nov 2025 | 689 | 101,956 (0%) | 0% | 82.6 | 56,932 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 84.67 per share. | 25 Nov 2025 | 574 | 100,625 (0%) | 0% | 84.7 | 48,601 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 84.61 per share. | 25 Nov 2025 | 289 | 100,805 (0%) | 0% | 84.6 | 24,452 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.34 per share. | 25 Nov 2025 | 200 | 100,625 (0%) | 0% | 85.3 | 17,068 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.37 per share. | 25 Nov 2025 | 200 | 100,625 (0%) | 0% | 85.4 | 17,074 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.17 per share. | 25 Nov 2025 | 180 | 100,625 (0%) | 0% | 85.2 | 15,331 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 21,206 | 49,644 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 80.19 per share. | 24 Nov 2025 | 21,206 | 100,625 (0%) | 0% | 80.2 | 1,700,509 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 24 Nov 2025 | 21,206 | 121,831 (0%) | 0% | 33.0 | 700,222 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 80.17 per share. | 24 Nov 2025 | 6,101 | 100,625 (0%) | 0% | 80.2 | 489,117 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 24 Nov 2025 | 6,101 | 106,726 (0%) | 0% | 33.0 | 201,455 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 6,101 | 11,399 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 4,715 | 10,885 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 80.15 per share. | 24 Nov 2025 | 4,715 | 100,625 (0%) | 0% | 80.1 | 377,907 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 24 Nov 2025 | 4,715 | 105,340 (0%) | 0% | 18.0 | 84,917 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 24 Nov 2025 | 1,900 | 102,525 (0%) | 0% | 18.0 | 34,219 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 1,900 | 15,600 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 80.14 per share. | 24 Nov 2025 | 1,900 | 100,625 (0%) | 0% | 80.1 | 152,266 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 1,650 | 70,850 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 80.14 per share. | 24 Nov 2025 | 1,650 | 100,625 (0%) | 0% | 80.1 | 132,231 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 24 Nov 2025 | 1,650 | 102,275 (0%) | 0% | 33.0 | 54,483 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2025 | 51,558 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 03 Oct 2025 | 51,558 | 152,183 (0%) | 0% | 30.9 | 1,591,080 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 66.45 per share. | 03 Oct 2025 | 23,863 | 104,901 (0%) | 0% | 66.4 | 1,585,696 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 65.45 per share. | 03 Oct 2025 | 23,419 | 128,764 (0%) | 0% | 65.5 | 1,532,774 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 67.15 per share. | 03 Oct 2025 | 4,276 | 100,625 (0%) | 0% | 67.1 | 287,133 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 03 Oct 2025 | 3,442 | 104,067 (0%) | 0% | 30.9 | 106,220 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2025 | 3,442 | 51,558 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 66.56 per share. | 03 Oct 2025 | 1,760 | 100,698 (0%) | 0% | 66.6 | 117,146 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 65.46 per share. | 03 Oct 2025 | 1,609 | 102,458 (0%) | 0% | 65.5 | 105,325 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 67.16 per share. | 03 Oct 2025 | 73 | 100,625 (0%) | 0% | 67.2 | 4,903 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 50.12 per share. | 19 Feb 2025 | 1,578 | 100,353 (0%) | 0% | 50.1 | 79,096 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 50.10 per share. | 19 Feb 2025 | 1,300 | 101,931 (0%) | 0% | 50.1 | 65,125 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 50.09 per share. | 19 Feb 2025 | 34 | 5,941 (0%) | 0% | 50.1 | 1,703 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 50.12 per share. | 19 Feb 2025 | 34 | 5,907 (0%) | 0% | 50.1 | 1,704 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 44.50 per share. | 07 Jan 2025 | 1,552 | 103,231 (0%) | 0% | 44.5 | 69,064 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 45.34 per share. | 07 Jan 2025 | 1,265 | 104,783 (0%) | 0% | 45.3 | 57,355 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 44.50 per share. | 07 Jan 2025 | 107 | 5,975 (0%) | 0% | 44.5 | 4,762 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 45.35 per share. | 07 Jan 2025 | 55 | 6,082 (0%) | 0% | 45.3 | 2,494 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 19,000 | 106,048 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 715 | 6,137 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 66,956 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.00 per share. | 02 Dec 2024 | 66,956 | 153,158 (0%) | 0% | 51 | 3,414,756 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 51.97 per share. | 02 Dec 2024 | 58,345 | 94,813 (0%) | 0% | 52.0 | 3,032,190 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 52.72 per share. | 02 Dec 2024 | 8,611 | 86,202 (0%) | 0% | 52.7 | 453,972 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.00 per share. | 02 Dec 2024 | 2,594 | 88,796 (0%) | 0% | 51 | 132,294 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 2,594 | 66,956 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 51.85 per share. | 02 Dec 2024 | 2,328 | 86,468 (0%) | 0% | 51.9 | 120,707 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.00 per share. | 02 Dec 2024 | 2,060 | 6,636 (0%) | 0% | 51 | 105,060 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 2,060 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 51.85 per share. | 02 Dec 2024 | 1,783 | 4,853 (0%) | 0% | 51.9 | 92,449 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 52.76 per share. | 02 Dec 2024 | 277 | 4,576 (0%) | 0% | 52.8 | 14,615 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 52.73 per share. | 02 Dec 2024 | 266 | 86,202 (0%) | 0% | 52.7 | 14,026 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 19,000 | 80,202 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 6,000 | 86,202 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 870 | 4,576 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 27.25 per share. | 30 Jan 2024 | 618 | 61,202 (0%) | 0% | 27.3 | 16,841 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 27.25 per share. | 30 Jan 2024 | 28 | 3,706 (0%) | 0% | 27.3 | 763 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 29.02 per share. | 08 Jan 2024 | 1,521 | 61,820 (0%) | 0% | 29.0 | 44,132 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 28.64 per share. | 08 Jan 2024 | 1,236 | 63,341 (0%) | 0% | 28.6 | 35,399 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 29.01 per share. | 08 Jan 2024 | 100 | 3,734 (0%) | 0% | 29.0 | 2,901 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 28.64 per share. | 08 Jan 2024 | 53 | 3,834 (0%) | 0% | 28.6 | 1,518 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 45.63 per share. | 31 Jan 2023 | 630 | 63,949 (0%) | 0% | 45.6 | 28,746 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 45.64 per share. | 31 Jan 2023 | 28 | 3,259 (0%) | 0% | 45.6 | 1,278 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 47.45 per share. | 24 Jan 2023 | 44 | 3,287 (0%) | 0% | 47.5 | 2,088 | Common Stock |